Every recall we track for Genentech, Inc. — 11 in all — plus the complaints and injury reports the public filed about them.
Genentech recalls 2mg Cathflo Activase vials with deformed stoppers that may cause contamination. Affected lots expire 01/31/2026. Stop using immediately to avoid infection risks.
Genentech recalls Susvimo (ranibizumab injection) due to defective delivery system causing implants to become non-functional. Affected lots expire by 2027.
Genentech recalls Xolair 150mg prefilled syringes due to stability problems detected at 12 months. Affected lots expired August 2021. No remedy specified in official notice.